Alembic Pharma's consolidated profit rose 21% to Rs 185 crore in Q2 FY26, led by strong performance in US generics, APIs, and ...

Alembic Pharmaceuticals reported a strong second quarter with profit rising 21% year-on-year to ₹185 crore, supported by ...

N-CAPIE offers a faster way to create and continuously optimise API implementations, says Sam Selmer-Olsen, MD at Bateleur Software.

Empowering Next-Gen Bioconjugates (ADCs/XDCs): Apeloa provides high-purity linkers and comprehensive chemistry services to accelerate your ADC, targeted conjugation, and peptide drug development ...

The plant-based API market is primed for growth due to heightened demand for sustainable, natural therapeutics and regulatory acceptance. Advances in extraction and purification improve reliability ...

Alembic Pharmaceuticals rallied 3.87% to Rs 960.10 after the company's consolidated net profit jumped 20.40% to Rs 184.71 crore in Q2 FY26, compared to Rs 153.41 crore posted in Q2 FY25.

Greg Miraglia and Jeff Nardinelli of Quinn Emanuel Urquhart & Sullivan LLP discuss the potential and successes of low-orbit ...

Strava moved to dismiss its lawsuit against Garmin this week, ending the patent dispute saga concerning live segment and heat ...

Abbvie (($ABBV)) has held its Q3 earnings call. Read on for the main highlights of the call. AbbVie’s latest earnings call ...

Edition" report has been added to ResearchAndMarkets.com's offering.The global healthcare CMO market was valued at US$145.83 billion in 2023, and is predicted to grow to US$291.25 billion in 2029. The ...